The CHMP renders a positive opinion recommending approval for MRK's Keytruda for the first-line treatment of malignant ...
A new treatment approach developed at Roswell Park Comprehensive Cancer Center has shown promising results in a phase 1 clinical trial ...
Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback